Ipamorelin Research Material — Product Overview
Ipamorelin is a synthetic pentapeptide used in experimental peptide and receptor-signaling research.
The compound was originally characterized as a selective growth hormone secretagogue and has been investigated in laboratory systems involving the growth hormone secretagogue receptor, commonly abbreviated GHSR.
Nexigen Ipamorelin 10 mg is supplied exclusively as a laboratory research material for analytical and scientific investigation.
The information on this page is provided to identify the compound, summarize relevant experimental research context and provide access to available batch-specific documentation.
This product is intended strictly for laboratory research and is not intended for human or veterinary use or consumption.
Ipamorelin 10 mg — Research Specifications
| Specification | Information |
| Compound | Ipamorelin |
| Quantity | 10 mg |
| Compound Type | Synthetic pentapeptide |
| CAS Number | 170851-70-4 |
| Molecular Formula | C38H49N9O5 |
| Molecular Weight | 711.9 g/mol |
| Sequence | Aib-His-D-2-Nal-D-Phe-Lys-NH2 |
| Form | Verify actual supplied form |
| Brand | Nexigen Peptides |
| Lot / Batch | Refer to current product documentation |
| Analytical Method | Refer to applicable batch documentation |
| Reported Result | Refer to applicable batch documentation |
| Intended Use | Laboratory research only |
The CAS number, formula, molecular weight and condensed sequence above are supported by PubChem.
What Is Ipamorelin?
Ipamorelin is a synthetic peptide consisting of five amino-acid-related residues and was developed through research involving growth hormone secretagogue peptides.
Published experimental work characterized Ipamorelin as interacting with the growth hormone secretagogue receptor pathway. Early laboratory studies investigated its receptor-associated activity using controlled cellular and animal models.
Ipamorelin is commonly discussed in scientific literature alongside research involving the ghrelin receptor/GHSR system, a G-protein-coupled receptor signaling pathway that continues to be studied in modern molecular and endocrine biology. Current research continues to expand understanding of GHSR signaling, receptor interactions and related cellular pathways.
Nexigen Peptides supplies Ipamorelin exclusively as a laboratory research peptide material.
Ipamorelin Research Context
Ipamorelin has been examined in published experimental literature involving peptide-receptor interactions and growth hormone secretagogue receptor signaling.
One of the compound’s foundational studies characterized Ipamorelin in controlled in-vitro and animal experimental systems and identified it as a selective growth hormone secretagogue within the research model used.
Subsequent studies used Ipamorelin in additional experimental systems to investigate the behavior of ghrelin-receptor agonists and related physiological signaling pathways.
When interpreting these publications, researchers should consider:
Experimental model — Results from cellular, animal or other experimental systems should be interpreted within the limitations of the model used.
Assay methodology — Receptor assays, biochemical measurements and other experimental techniques can produce different types of information.
Research conditions — Concentration, exposure time, sample preparation and model characteristics can materially affect experimental observations.
Compound characterization — Researchers should understand the identity and analytical characteristics of the research material used in an experiment.
Publication date and methodology — Much of the compound-specific Ipamorelin literature is older, while modern GHSR research continues to refine understanding of the underlying receptor biology.
Scientific references are provided solely to describe areas of laboratory investigation.
They do not establish that Nexigen Ipamorelin is safe, effective or appropriate for human or veterinary use.
Experimental Research Characteristics
Scientific literature has examined Ipamorelin in experimental systems involving growth hormone secretagogue receptor activity.
The growth hormone secretagogue receptor (GHSR) belongs to the broader family of G-protein-coupled receptors, or GPCRs. Modern receptor research continues to investigate how GPCR signaling can involve multiple intracellular pathways, receptor interactions and context-dependent cellular responses.
Because receptor biology can be highly dependent on the experimental system, results observed in one assay or model should not automatically be generalized to another.
Researchers evaluating Ipamorelin should consult the original peer-reviewed publications when selecting laboratory methods or interpreting experimental observations.
Nexigen Peptides does not represent laboratory, animal or other experimental findings as established human or veterinary outcomes.
Evaluating Ipamorelin as a Research Peptide
Researchers sourcing Ipamorelin or other research peptides should evaluate more than the compound name or nominal vial quantity.
Compound Identification
The material should be identified using recognized chemical information such as compound name, CAS number, molecular formula and applicable sequence information.
Lot Traceability
Researchers should be able to determine which product lot corresponds to the available analytical documentation.
Analytical Method
Testing records should identify the analytical methodology used whenever that information is available.
Batch-Specific Results
A result generated for one batch should not automatically be assumed to characterize another batch.
Documentation Availability
Certificates of Analysis and supporting analytical information should be accessible to the research customer whenever such documentation is available.
Research-Use Designation
The intended laboratory purpose of the material should be clearly communicated.
Nexigen’s objective is to provide research customers with transparent product and lot information so that materials can be evaluated using documented analytical information rather than generalized promotional claims.
Ipamorelin Batch Documentation
Nexigen Peptides provides available batch-specific analytical documentation associated with its research materials.
Depending upon the testing completed for a particular Ipamorelin lot, documentation may include:
- Compound identification
- Lot or batch number
- Testing date
- Analytical methodology
- Reported chromatographic result
- Identity-related analytical information
- Testing laboratory information
- Original analytical report
Results associated with one lot apply only to the material identified in that documentation and should not automatically be generalized to another batch.
How Is Ipamorelin Research Material Evaluated?
Different analytical techniques provide different information about a peptide research material.
High-Performance Liquid Chromatography
High-performance liquid chromatography, commonly abbreviated HPLC, can be used to separate components within a peptide sample and evaluate chromatographic composition under defined analytical conditions.
The resulting chromatogram can provide information about the relative chromatographic profile of the analyzed material.
Mass Spectrometry
Mass spectrometry, when performed, can provide molecular information useful in evaluating whether detected material is consistent with the expected compound.
The two methods do not answer precisely the same analytical question.
For this reason, researchers should evaluate the actual testing performed on the applicable Ipamorelin batch rather than treating a single generalized purity percentage as complete characterization.
Why Batch-Specific Testing Matters for Research Peptides
Synthetic peptide materials are produced and evaluated in defined batches.
A product name identifies the intended compound, but analytical evidence should be associated with the actual material tested.
Batch-specific documentation can help researchers determine:
- which material was evaluated
- which lot was tested
- when testing was performed
- which analytical method was used
- what result was reported
- whether the documentation corresponds to the material being ordered
For this reason, Nexigen recommends reviewing current lot documentation instead of relying exclusively on generalized company-level purity statements.
Laboratory Handling
Handling and preparation requirements depend upon the research design, analytical methodology and experimental protocol.
Researchers should follow validated laboratory procedures, applicable scientific literature and available lot-specific documentation when preparing or handling Ipamorelin research material.
Nexigen Peptides does not provide human or veterinary preparation, dosing, injection or administration instructions.
Storage of Ipamorelin Research Material
Store Ipamorelin according to the conditions specified in the applicable product documentation and available lot-specific analytical records.
Laboratory personnel should use appropriate procedures to minimize unnecessary exposure to moisture, light, temperature fluctuations and other environmental conditions that could affect research-material integrity.
Where validated compound-specific or batch-specific stability information is available, researchers should follow that information rather than generalized storage recommendations.
Ipamorelin Scientific Research References
Researchers investigating Ipamorelin should consult primary scientific literature and current research concerning the growth hormone secretagogue receptor system.
Selected references include:
Ipamorelin, the First Selective Growth Hormone Secretagogue
The original pharmacological characterization described the development and experimental evaluation of Ipamorelin in cell and animal research systems.
Source: Raun K, et al. European Journal of Endocrinology.
PubMed PMID: 9849822.
Pharmacokinetic-Pharmacodynamic Modeling of Ipamorelin
A subsequent publication examined Ipamorelin pharmacokinetics and pharmacodynamic measurements under a controlled clinical research protocol.
PubMed PMID: 10496658.
Experimental Ghrelin-Receptor Research
Ipamorelin has also been used as a ghrelin-receptor agonist in experimental animal research systems.
Current GHSR Biology
Recent 2026 research continues to investigate the underlying biology of ghrelin and GHSR signaling in experimental systems, illustrating that this receptor pathway remains an active area of research.
Ipamorelin Research Peptide FAQ
What is Ipamorelin?
Ipamorelin is a synthetic pentapeptide originally developed and investigated as a growth hormone secretagogue in experimental research systems. It has been studied in connection with growth hormone secretagogue receptor signaling.
Is Ipamorelin a research peptide?
Yes. Ipamorelin is a synthetic peptide commonly investigated in experimental peptide and receptor-signaling research.
How many amino-acid residues are in Ipamorelin?
Ipamorelin is a pentapeptide consisting of five amino-acid-related residues.
What is the Ipamorelin sequence?
The commonly reported condensed Ipamorelin sequence is Aib-His-D-2-Nal-D-Phe-Lys-NH2.
What is the CAS number for Ipamorelin?
Ipamorelin is identified by CAS 170851-70-4.
What is the molecular formula of Ipamorelin?
PubChem reports the molecular formula as C38H49N9O5.
What is the molecular weight of Ipamorelin?
PubChem reports a molecular weight of approximately 711.9 g/mol.
Does Nexigen provide Ipamorelin batch documentation?
Available lot-specific documentation can be reviewed through the Nexigen Batch Documentation section and, where applicable, directly from the corresponding product record.
Researchers should confirm that documentation corresponds to the specific lot being evaluated.
How can Ipamorelin research-material purity be evaluated?
Chromatographic techniques such as HPLC can be used to evaluate sample composition and chromatographic purity. Other analytical methods may provide complementary molecular or identity information depending on the testing performed.
Does Nexigen provide Ipamorelin dosing instructions?
No. Nexigen does not provide human or veterinary dosing recommendations, injection instructions, administration guidance or treatment protocols.
What is Nexigen Ipamorelin intended for?
Nexigen Ipamorelin is supplied exclusively for legitimate laboratory, analytical and scientific research.
Research Use Only
Nexigen Ipamorelin 10 mg is supplied exclusively for legitimate laboratory, analytical and scientific research.
This product is not intended for human or veterinary use or consumption, clinical use, diagnosis, treatment, cure or prevention of disease.
Nexigen Peptides does not provide medical advice, human or veterinary dosing recommendations, injection instructions or administration guidance.
